Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SynAct Pharma Major Shareholding Notification 2024

Mar 12, 2024

3114_iss_2024-03-12_5e517090-795f-42e1-a2e7-07717d446e0e.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

Issuer SynAct Pharma AB

Holder

Nordnet AB (publ)

Instrument

Instrument Aktie SE0008241491
Before the transaction
Shares Data not given*
Voting rights Data not given*
Transaction
Reason for major shareholding notification Buy
Date 11/03/2024
Limit for number of shares 5 %
Limit for number of votes 5 %
After the transaction
Quantity
Shares 1,782,146
Directly held voting rights 0
Indirectly held voting rights 1,782,146
Percentage
Directly held shares 5.01011 %
Directly held voting rights 0 %
Indirectly held voting rights 5.01011 %

Resulting distribution of total holdings

Percentage of voting
rights:
Number of underlying
shares:
Shares 5.01011 % 1,782,146
Instruments - FITA Ch. 4, section 2, first
paragraph, line 2
Instruments - FITA Ch. 4, section 2,
first paragraph, line 3
- Physically settled
- Cash settled 0.00281 % 1,000
Total 5.01292 % 1,783,146

Chain of controlling companies

Voting rights % Voting rights Company
1,737,999 4.886 Nordnet Pensionsförsäkring AB
0.12692 Nordnet Livsforsikring AS
Group
total
holdings
Voting rights
1,783,146
Percentage of voting rights 5.01292

Published

12/03/2024 14:18
Contact
Name Felix Mandoki
Phone +46766110734 Email [email protected]

*Source of information has chosen not to submit the data

CLOSE PRINT

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25